25M

Eyenuk gained $25 million in Sequence A funding to broaden entry to its AI-powered eye-screening technology that enables autonomous detection of diabetic retinopathy (DR) for the duration of a patient’s common test. The the latest raise was led by AXA IM Alts and joined by new and present traders, which […]